Compare AbCellera Biologics Inc (ABCL) vs SMX Security Matters plc (SMX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs SMX Security Matters plc — how do they compare? AbCellera Biologics Inc trades at $7.2 (market cap $2.35B), while SMX Security Matters plc trades at $15.88 (market cap $15.08M). The key difference: AbCellera Biologics Inc is far larger — about 155.8× SMX Security Matters plc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| ABCL | SMX | |
|---|---|---|
Market Cap | $2.35B | $15.08M |
Sector | Health | Technology |
52-Week High | $8.12 | $569.32K |
52-Week Low | $2.78 | $12.87 |
Enterprise Value | $1.99B | $12.05M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
SMX (Security Matters PLC) trades at $16.955, up 12.66% today, following two reverse stock splits in May and June 2026. The technical outlook is neutral with mixed moving averages and oscillators, while fundamentals show a P/B of 1.84 but negative ROE and ROA. Recent news highlights the company's focus on recycled plastic traceability and regulatory tailwinds from state recycling mandates.
Outlook is speculative given negative profitability and recent corporate actions. Investment opportunity hinges on adoption of its Circularity-as-a-Service platform, but risks include execution challenges and intense competition in sustainability tech. Wall Street sentiment appears cautious pending evidence of revenue growth and margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
